Investor Update
Basel, 19 July 2011
Anti-Human IL-6 Receptor Monoclonal Antibody "Actemra" Subcutaneous Injection Demonstrates Efficacy in Rheumatoid Arthritis in Phase III Clinical Study
Dear Investor,
Please find attached a press release by Chugai.
Do not hesitate to contact us for any further questions.